Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
GLP-1 receptor agonists, metabolic syndrome, and Alzheimer’s disease: Lessons and opportunities from the EVOKE trials
Journal of neuroendocrinology;38(8):e70246
Reframing GLP-1 Therapies as Cardiometabolic Health Drugs: Beyond the Race to Weight Loss
Journal of the American College of Cardiology;88(6):649-651
Burden and Risk of Depression in Patients Receiving Semaglutide: A Systematic Review and Meta-Analysis
Clinical obesity;16(5):e70105
Association of Glucagon-Like Peptide-1 Receptor Analogues and Laryngeal Symptoms in Obese Adults
The Laryngoscope, 2026
From Pathobiology to Prescribing in Obesity-Driven HFpEF: A Systematic Review and Practical Therapeutic Framework
Current problems in cardiology, 2026;:103423
Beyond Weight Loss: Tirzepatide as a Metabolic Disease-Modifying Strategy for Metabolic Dysfunction-Associated Steatohepatitis: A Narrative Review
Health science reports, 2026;9(8):e73044
Semaglutide Attenuates Type 2 Diabetes-Induced Neurotoxicity by Modulating Neuroinflammation, Oxidative Stress, and Neuroapoptosis
Life (Basel, Switzerland), 2026;16(8)
GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide)/GLP-1 Receptor Agonists for Antipsychotic-Induced Weight Gain: A Narrative Review
Cureus, 2026;18(8):e114435
Diabetes, Adiposity, and Functional Phenotypes in HFpEF: A Systematic Review of Recent Treatment-Response Evidence
Cureus, 2026;18(8):e114404
Liver Fat Changes in Patients With Type 2 Diabetes by Presence of Genetic Hepatic Steatosis: A Post Hoc Analysis of SURPASS-3 MRI
Liver international : official journal of the International Association for the Study of the Liver;46(9):e70837
Peptide Supplements and Their Therapeutic Applications in Sports Medicine
The American journal of sports medicine, 2026;:3635465261464420
Simplified definition and imaging-based stratification of at-risk MASH using magnetic resonance elastography
Hepatology communications, 2026;10(9)
Correction: Cost-Effectiveness of Endoscopic Bariatric Therapies Compared with Laparoscopic Sleeve Gastrectomy and Semaglutide
Obesity surgery, 2026
Design, synthesis, and stability evaluation of semaglutide-derived lactam-stapled peptide scaffolds for GLP-1R targeting
Journal of enzyme inhibition and medicinal chemistry, 2026;41(1):2714331
MAFLD/MASLD: Past, Present, and Future
Journal of gastroenterology and hepatology, 2026
Obesity management for kidney TRANSPLANTation: protocol for the vanguard phase of an innovative randomised controlled trial, embedded in routine care (OK-TRANSPLANT 2)
BMJ open, 2026;16(8):e120427
Semaglutide vs Metabolic and Bariatric Surgery and Cardiovascular Outcomes in Obesity
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2026
EQ-5D Health Utility Gains with Once-Weekly Semaglutide 2.4 mg in People with MASH and F2/F3 Fibrosis: An Analysis of ESSENCE
JHEP reports : innovation in hepatology, 2026;:101993
Semaglutide/Acarbose combination protects against diabetic nephropathy in rats; a novel insight into modulation of Nrf-2/HO-1& TGF-β/Smad pathways
International immunopharmacology, 2026;187:117277
Neuropsychiatric Effects of Glucagon-Like Peptide-1 Receptor Agonists in Schizophrenia-Spectrum Disorders: A Systematic Review
Cureus, 2026;18(8):e114350